Recent Company News

• 02:52 AM ET Jul 04, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:02 AM ET Jul 04, 2025
  

  AstraZeneca's Imfinzi approved in the EU for bladder cancer (10204.0000p, 0)

• 10:26 AM ET Jul 03, 2025
  

  Summit Therapeutics in discussions with AstraZeneca for partnership deal for up to $15B - Bloomberg ($22.79, +0.17)

• 02:11 AM ET Jul 02, 2025
  

  European macro headlines:

• 02:50 PM ET Jul 01, 2025
  

  FDA approves FluMist for 2025-26 US formulation (10402.0000p, 0)

• 10:40 AM ET Jul 01, 2025
  

  AstraZeneca CEO reportedly wants to move the company listing, and possibly its domicile, to the US - The Times ($71.56, +1.68)

• 01:14 PM ET Jun 26, 2025
  

  CDC ACIP votes 6-0-1 to recommend routine annual influenza vaccination

• 08:52 AM ET Jun 26, 2025
  

  CDC ACIP recommends clesrovimab for infants entering their first RSV season ($79.67, 0.00)

• 06:36 AM ET Jun 26, 2025
  

  UK government has accepted advice from the JCVI for the autumn 2025 COVID-19 vaccination program

• 05:40 PM ET Jun 25, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market